RNXT RenovoRx, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

RenovoRx (RNXT) Stock: Buy, Sell, or Hold?

$1.16
-0.06 (-4.92%) ▼
5d: -2.52% 30d: +3.57% 90d: -17.14%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$1.18 – $1.47
Position: OVERSOLD
Forward P/E & Valuation
-9.7x
Next 12M consensus est.
Wall Street Target
$7.25
+525.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.88 / $1.55
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: RNXT shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When RNXT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: RNXT is currently trading at $1.16, which is considered oversold relative to its 30-day fair value range of $1.18 to $1.47.

Technical Outlook: Technically, RNXT is in a uptrend. Immediate support is located at $0.88, while resistance sits at $1.55. Short-term momentum is weak, with the stock down 4.9% recently.

Market Sentiment: RNXT scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.25 (+525.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.18 - $1.47
Company Quality Score 41/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $1.18 - $1.47
Current vs Trading Range OVERSOLD
Support Level $0.88
Resistance Level $1.55
Current Trend Uptrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (30/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.9%)
  • BULLISH: Trading 525.0% below Wall St target ($7.25)
  • WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -9.67
Wall Street Target $7.25 (+525.0%)
Revenue Growth (YoY) 115.4%
Share RNXT Analysis

Share this live RNXT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (RNXT)

Bearish 3 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits shows a bullish sentiment towards $RNXT with one user expressing optimism about the stock's potential through Q2 2027.
Key Retail Themes: Long-term Bullishness
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for RNXT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$107 65 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 37 SELL
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 58 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$86 46 HOLD
IMNM
Immunome Inc
STRONG BUY
17 analysts
$35 46 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive RNXT Research Pages
RNXT Technical Chart RNXT Price Prediction RNXT Intrinsic Value DCF RNXT Earnings Date Why is RNXT Moving Today? RNXT Investment Advisor RNXT Fair Price Analyzer RNXT Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals